Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority
- PMID: 25845035
- PMCID: PMC4385065
- DOI: 10.2450/2015.0057-15
Which patients with venous thromboembolism should receive non-vitamin K antagonist oral anticoagulants? The majority
Comment in
-
The use of novel oral anticoagulants: the debate continues!Blood Transfus. 2015 Apr;13(2):170-1. doi: 10.2450/2015.0059-15. Blood Transfus. 2015. PMID: 25845033 Free PMC article. No abstract available.
References
-
- Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet. 2012;379:1835–46. - PubMed
-
- Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e419S–94S. Erratum in: Chest 2012; 142: 1698–704. - PMC - PubMed
-
- Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35:3033–69. - PubMed
-
- Konstantinides S, Goldhaber SZ. Pulmonary embolism: risk assessment and management. Eur Heart J. 2012;33:3014–22. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical